Healthcare BPO Market to Showcase Vigorous Demand during the Period until 2027 – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Dr. Mario Rocci Joins The IMA Group as Strategic Advisor in Clinical Research
Share Article
The IMA Group announced today that industry veteran Dr. Mario Rocci has joined the company s Clinical Research division as its new Strategic Advisor. Dr. Rocci will help expand the company s office-based, decentralized and virtual clinical trials. TARRYTOWN, N.Y. (PRWEB) January 12, 2021 Mario Rocci, PhD, FCP, FFIP, a seasoned executive with 35 years of scientific and business management experience, has joined The IMA Group (IMA) as Strategic Advisor in the Clinical Research division.
IMA Clinical Research is a network of integrated research sites specializing in Phase II-IV clinical trials in multiple therapeutic areas. IMA performs trials with a flexible model using both their physical locations and virtual capabilities that reach people around the country to support the advancement of safe and effective medication the